how-xermelo-helps

XERMELO provides meaningful reductions in diarrhea

Nearly 9 out of 10 people taking XERMELO had a reduction in diarrhea frequency Nearly 9 out of 10 people taking XERMELO had a reduction in diarrhea frequency

It may take up to 12 weeks to see a benefit from XERMELO, however, many people saw improvement within 3 weeks.

How XERMELO was studied

In a clinical study, some patients with Carcinoid Syndrome received XERMELO along with SSA injections. Other patients received SSA injections alone. All were followed for 12 weeks, and observed for reductions in daily diarrhea.

In a study, only those taking XERMELO reported being "very satisfied"

People from the clinical study were asked to rate treatment satisfaction from “very dissatisfied” to “very satisfied.” Among the 33 people who answered this question, 12 out of 24 taking XERMELO + SSA reported being “very satisfied” versus 0 out of 9 taking SSA alone.

Treatment with XERMELO includes SSA + XERMELO, rather than an SSA alone. Treatment with XERMELO includes SSA + XERMELO, rather than an SSA alone

Remember to talk to your doctor to see if XERMELO may be right for you.

See how XERMELO can fit into your everyday schedule
Learn more

Social Image

Important Safety Information and Indication

Important Safety Information and Indication

Important Safety Information

  • XERMELO may cause constipation which can be serious. You should stop taking XERMELO if severe constipation or severe, persistent, or worsening abdominal pain develops. Talk to your doctor if you have these symptoms
  • The most common side effects of XERMELO include nausea, headache, increase in hepatic enzymes, depression, flatulence, decreased appetite, swelling of your hands and feet, and fever
  • Talk to your doctor about all medicines you are taking as some may interact with XERMELO

Indication

XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for Carcinoid Syndrome diarrhea in adults who are not adequately controlled by SSA therapy.

For more information about XERMELO, talk to your doctor or see Full Prescribing Information.

You may report an adverse event related to Lexicon products by calling 1-844-LEX-PHAR (1-844-539-7427)  (US only). If you prefer, you may contact the US Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch or call 1-800-FDA-1088.